IP Verse

Aerosol Formulation For The Inhalation Of Beta Agonists - EP1940349

The patent EP1940349 was granted to Boehringer Ingelheim on Feb 14, 2018. The application was originally filed on Oct 6, 2006 under application number EP06807028A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP1940349

BOEHRINGER INGELHEIM
Application Number
EP06807028A
Filing Date
Oct 6, 2006
Status
Opposition Rejected
Jul 10, 2020
Grant Date
Feb 14, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSNov 13, 2018ELKINGTON AND FIFE -

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP0073505
INTERNATIONAL-SEARCH-REPORTWO0183462
INTERNATIONAL-SEARCH-REPORTWO2004045618
INTERNATIONAL-SEARCH-REPORTWO2005102349
OPPOSITIONCA2473815
OPPOSITIONCA2506082
OPPOSITIONEP0073505
OPPOSITIONEP0418716
OPPOSITIONWO0183462
OPPOSITIONWO03084519
OPPOSITIONWO2004045618
OPPOSITIONWO2005102349

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- CALVO G M ET AL, "IS IT USEFUL TO ADD AN ANTICHOLINERGIC TREATMENT TO BETA2-ADRENERGIC MEDICATION IN ACUTE ASTHMA ATTACK", JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, BARCELONA, ES, (199801), vol. 8, no. 1, ISSN 1018-9068, pages 30 - 34, XP009018610 [X] 1-22 * the whole document *-
OPPOSITION- CALVO G. et al., "IS IT USEFUL TO ADD AN ANTICHOLINERGIC TREATMENT TO BETA2-ADRENERGIC MEDICATION IN ACUTE ASTHMA ATTACK", Journal of Investigative Allergology and Clinical Immunology, (19980100), vol. 8, no. 1, pages 30 - 34, XP009018610-
OPPOSITION- "chapter 37: Anticholinergic Bronchodilators", Barnes P. J. et al., ASTHMA. Basic Mechanisms and Clinical Management. 3rd ed., Academic Press, (19980000), pages 677 - 688, XP055529487-
OPPOSITION- "The global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease", Global Initiative for Chronic Obstructive Lung Disease (GOLD), (20050000), XP055532091-
OPPOSITION- R.C. TENNANT et al., "Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?", Current Opinion in Pharmacology, (20030600), vol. 3, pages 270 - 276, XP055529479

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents